TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucoma

UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.

Oragenics CEO Alan Joslyn Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal

The Tampa Bay Business Journal recognized Alan Joslyn, president and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, for being part of the region’s top health care innovators. The feature was part […]

Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal

The Tampa Bay Business Journal recognized Patricia Lawman, founder and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate company  Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, for being part of the region’s top health care innovators. The feature was part of the Florida Business Journal’s statewide Future of Health Care […]

Patricia Lawman Develops Novel Cell and Gene Therapies to Fight Cancer

Patricia Lawman is on a mission to change the future of cancer care. After losing her parents to lung cancer and lymphoma, respectively, she recognized the detrimental impact of radiation and chemotherapy. She knew there must be a way to treat a patient’s cancer without the risk of toxicity and other negative side effects. After […]